[Form 4] iRhythm Technologies, Inc Insider Trading Activity
Marc Rosenbaum, Chief Accounting Officer of iRhythm Technologies (IRTC), sold 226 shares of the company's common stock on 08/11/2025 at a reported price of $158.93 per share.
The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2025. Following the reported transaction Rosenbaum beneficially owns 10,879 shares, held directly. The filing identifies his relationship to the issuer as an officer (Chief Accounting Officer) and discloses the transaction as a planned disposition under the 10b5-1 framework.
Marc Rosenbaum, Chief Accounting Officer di iRhythm Technologies (IRTC), ha venduto 226 azioni del capitale sociale della societ脿 il 08/11/2025 a un prezzo riportato di $158.93 per azione.
Il Modulo 4 indica che la vendita 猫 stata effettuata in base a un piano di negoziazione Rule 10b5-1 istituito dalla persona che ha effettuato la comunicazione il 12 maggio 2025. Dopo la transazione segnalata, Rosenbaum detiene beneficiariamente 10,879 azioni, possedute direttamente. La comunicazione identifica il suo rapporto con l'emittente come dirigente (Chief Accounting Officer) e dichiara la transazione come una cessione programmata ai sensi del regime 10b5-1.
Marc Rosenbaum, Chief Accounting Officer de iRhythm Technologies (IRTC), vendi贸 226 acciones de las acciones ordinarias de la compa帽铆a el 08/11/2025 a un precio informado de $158.93 por acci贸n.
El Formulario 4 indica que la venta se realiz贸 conforme a un plan de negociaci贸n Rule 10b5-1 establecido por la persona que informa el 12 de mayo de 2025. Tras la operaci贸n reportada, Rosenbaum posee beneficiariamente 10,879 acciones, en propiedad directa. La presentaci贸n identifica su relaci贸n con el emisor como funcionario (Chief Accounting Officer) y declara la transacci贸n como una disposici贸n planificada bajo el marco 10b5-1.
Marc Rosenbaum鞚� iRhythm Technologies (IRTC)鞚� 斓滉碃須岅硠毂呾瀯鞛� (Chief Accounting Officer)搿涤劀 226欤�鞚� 氤错喌欤茧ゼ 08/11/2025鞐� 欤茧嫻 鞁犼碃臧� $158.93鞐� 毵り皝頄堨姷雼堧嫟.
Form 4電� 頃措嫻 毵り皝鞚� 氤搓碃鞚胳澊 2025雲� 5鞗� 12鞚�鞐� 靹れ爼頃� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞚措（鞏挫雼り碃 氇呾嫓頃╇媹雼�. 氤搓碃霅� 瓯半灅 頉� Rosenbaum鞚� 鞁れ鞝侅溂搿� 10,879欤�毳� 歆侅爲 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖靹滊電� 氚滍枆靷檧鞚� 甏�瓿勲ゼ 鞛勳洂(Chief Accounting Officer)鞙茧 旮办灛頃橁碃 鞛堨溂氅�, 頃措嫻 瓯半灅毳� 10b5-1 頂勲爤鞛勳泴韥棎 霐半ジ 瓿勴殟霅� 觳橂秳鞙茧 瓿奠嫓頃橁碃 鞛堨姷雼堧嫟.
Marc Rosenbaum, Chief Accounting Officer d'iRhythm Technologies (IRTC), a vendu 226 actions des actions ordinaires de la soci茅t茅 le 08/11/2025 脿 un prix d茅clar茅 de $158.93 par action.
Le formulaire 4 indique que la vente a 茅t茅 effectu茅e en vertu d'un plan de n茅gociation Rule 10b5-1 茅tabli par la personne d茅clarante le 12 mai 2025. 脌 la suite de la transaction signal茅e, Rosenbaum d茅tient b茅n茅ficiairement 10,879 actions, d茅tenues directement. Le d茅p么t identifie sa relation avec l'茅metteur comme dirigeant (Chief Accounting Officer) et qualifie la transaction de cession planifi茅e dans le cadre de la r猫gle 10b5-1.
Marc Rosenbaum, Chief Accounting Officer von iRhythm Technologies (IRTC), verkaufte am 08/11/2025 226 Aktien des Stammkapitals des Unternehmens zu einem gemeldeten Preis von $158.93 je Aktie.
Das Formular 4 gibt an, dass der Verkauf gem盲脽 einem 搁耻濒别鈥�10产5鈥�1鈥慔补苍诲别濒蝉辫濒补苍 erfolgte, den die meldende Person am 12. Mai 2025 eingerichtet hat. Nach der gemeldeten Transaktion besitzt Rosenbaum wirtschaftlich 10,879 Aktien, die er direkt h盲lt. Die Einreichung bezeichnet seine Beziehung zum Emittenten als Vorstand (Chief Accounting Officer) und f眉hrt die Transaktion als geplante Ver盲u脽erung im Rahmen von 10b5鈥�1 auf.
- Sale executed under a Rule 10b5-1 trading plan established May 12, 2025, indicating a pre-arranged transaction
- Reporting person continues to hold 10,879 direct shares after the transaction
- None.
Insights
TL;DR: A small, pre-planned insider sale that is unlikely to be material to investors on its own.
The Form 4 documents a sale of 226 shares at $158.93 executed on 08/11/2025. The reporting person remains a direct beneficial owner of 10,879 shares. Because the sale was conducted under a Rule 10b5-1 plan established on May 12, 2025, it reflects a scheduled disposition rather than an ad hoc market move. On its face this is a routine compliance-driven transaction with limited standalone impact on valuation or operations.
TL;DR: Disclosure aligns with governance best practices; sale executed under an established 10b5-1 plan.
The filing identifies Marc Rosenbaum as Chief Accounting Officer and discloses the sale as executed pursuant to a Rule 10b5-1 trading plan dated May 12, 2025. The Form 4 provides the transaction price ($158.93), the number of shares sold (226) and shares remaining (10,879), meeting standard Section 16 disclosure requirements. From a governance standpoint this is a transparent, pre-arranged insider disposition consistent with policies that mitigate timing concerns.
Marc Rosenbaum, Chief Accounting Officer di iRhythm Technologies (IRTC), ha venduto 226 azioni del capitale sociale della societ脿 il 08/11/2025 a un prezzo riportato di $158.93 per azione.
Il Modulo 4 indica che la vendita 猫 stata effettuata in base a un piano di negoziazione Rule 10b5-1 istituito dalla persona che ha effettuato la comunicazione il 12 maggio 2025. Dopo la transazione segnalata, Rosenbaum detiene beneficiariamente 10,879 azioni, possedute direttamente. La comunicazione identifica il suo rapporto con l'emittente come dirigente (Chief Accounting Officer) e dichiara la transazione come una cessione programmata ai sensi del regime 10b5-1.
Marc Rosenbaum, Chief Accounting Officer de iRhythm Technologies (IRTC), vendi贸 226 acciones de las acciones ordinarias de la compa帽铆a el 08/11/2025 a un precio informado de $158.93 por acci贸n.
El Formulario 4 indica que la venta se realiz贸 conforme a un plan de negociaci贸n Rule 10b5-1 establecido por la persona que informa el 12 de mayo de 2025. Tras la operaci贸n reportada, Rosenbaum posee beneficiariamente 10,879 acciones, en propiedad directa. La presentaci贸n identifica su relaci贸n con el emisor como funcionario (Chief Accounting Officer) y declara la transacci贸n como una disposici贸n planificada bajo el marco 10b5-1.
Marc Rosenbaum鞚� iRhythm Technologies (IRTC)鞚� 斓滉碃須岅硠毂呾瀯鞛� (Chief Accounting Officer)搿涤劀 226欤�鞚� 氤错喌欤茧ゼ 08/11/2025鞐� 欤茧嫻 鞁犼碃臧� $158.93鞐� 毵り皝頄堨姷雼堧嫟.
Form 4電� 頃措嫻 毵り皝鞚� 氤搓碃鞚胳澊 2025雲� 5鞗� 12鞚�鞐� 靹れ爼頃� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 鞚措（鞏挫雼り碃 氇呾嫓頃╇媹雼�. 氤搓碃霅� 瓯半灅 頉� Rosenbaum鞚� 鞁れ鞝侅溂搿� 10,879欤�毳� 歆侅爲 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖靹滊電� 氚滍枆靷檧鞚� 甏�瓿勲ゼ 鞛勳洂(Chief Accounting Officer)鞙茧 旮办灛頃橁碃 鞛堨溂氅�, 頃措嫻 瓯半灅毳� 10b5-1 頂勲爤鞛勳泴韥棎 霐半ジ 瓿勴殟霅� 觳橂秳鞙茧 瓿奠嫓頃橁碃 鞛堨姷雼堧嫟.
Marc Rosenbaum, Chief Accounting Officer d'iRhythm Technologies (IRTC), a vendu 226 actions des actions ordinaires de la soci茅t茅 le 08/11/2025 脿 un prix d茅clar茅 de $158.93 par action.
Le formulaire 4 indique que la vente a 茅t茅 effectu茅e en vertu d'un plan de n茅gociation Rule 10b5-1 茅tabli par la personne d茅clarante le 12 mai 2025. 脌 la suite de la transaction signal茅e, Rosenbaum d茅tient b茅n茅ficiairement 10,879 actions, d茅tenues directement. Le d茅p么t identifie sa relation avec l'茅metteur comme dirigeant (Chief Accounting Officer) et qualifie la transaction de cession planifi茅e dans le cadre de la r猫gle 10b5-1.
Marc Rosenbaum, Chief Accounting Officer von iRhythm Technologies (IRTC), verkaufte am 08/11/2025 226 Aktien des Stammkapitals des Unternehmens zu einem gemeldeten Preis von $158.93 je Aktie.
Das Formular 4 gibt an, dass der Verkauf gem盲脽 einem 搁耻濒别鈥�10产5鈥�1鈥慔补苍诲别濒蝉辫濒补苍 erfolgte, den die meldende Person am 12. Mai 2025 eingerichtet hat. Nach der gemeldeten Transaktion besitzt Rosenbaum wirtschaftlich 10,879 Aktien, die er direkt h盲lt. Die Einreichung bezeichnet seine Beziehung zum Emittenten als Vorstand (Chief Accounting Officer) und f眉hrt die Transaktion als geplante Ver盲u脽erung im Rahmen von 10b5鈥�1 auf.
FAQ
What transaction is reported in the Form 4 for iRhythm (IRTC)?
At what price were the shares sold in the IRTC Form 4?
Was the sale by Marc Rosenbaum part of a 10b5-1 plan?
How many IRTC shares does the reporting person own after the transaction?
What is Marc Rosenbaum's role at iRhythm as disclosed in the filing?
When was the transaction reported to have occurred?
